藥學系

Medicine & Life Sciences

1. Taiwan 100%
2. Histone Deacetylase Inhibitors 81%
3. Neoplasms 65%
4. Inhibitory Concentration 50 52%
5. Apoptosis 52%
6. In Vitro Techniques 52%
7. Histone Deacetylases 41%
8. Growth 41%
9. Proteins 40%
10. Population 40%
11. Pharmaceutical Preparations 39%
12. Cell Line 38%
13. Lipopolysaccharides 35%
14. Anti-Inflammatory Agents 35%
15. Pharmacokinetics 34%
16. Therapeutics 34%
17. High Pressure Liquid Chromatography 33%
18. Mucocutaneous Lymph Node Syndrome 32%
19. Cohort Studies 31%
20. Antineoplastic Agents 31%
21. Colorectal Neoplasms 30%
22. Cyclooxygenase 2 30%
23. Antioxidants 30%
24. Breast Neoplasms 27%
25. Genes 27%
26. Tubulin 26%
27. Acids 26%
28. isosteviol 25%
29. Tubulin Modulators 25%
30. Nitric Oxide 24%
31. Water 24%
32. Micelles 23%
33. Down-Regulation 23%
34. Non-Small Cell Lung Carcinoma 23%
35. Macrophages 22%
36. Gene Expression 22%
37. Phosphorylation 22%
38. Autophagy 22%
39. aristolochic acid I 21%
40. Cell Movement 21%
41. Rabbits 20%
42. Microtubules 20%
43. Ethanol 20%
44. Biological Availability 20%
45. Resveratrol 20%
46. Cell Proliferation 20%
47. osthol 20%
48. Pyruvaldehyde 20%
49. Pharmacists 20%
50. Inflammation 20%
51. Heterografts 20%
52. Nanoparticles 20%
53. Xanthine Oxidase 20%
54. Lung Neoplasms 20%
55. Colonic Neoplasms 19%
56. Nitric Oxide Synthase Type II 19%
57. Lignans 19%
58. Drug Delivery Systems 19%
59. indoline 18%
60. Lactic Acid 17%
61. Kidney 17%
62. Dinoprostone 17%
63. Single Nucleotide Polymorphism 17%
64. Interleukin-1 17%
65. 3-(1-benzenesulfonyl-2,3-dihydro-1H-indol-5-yl)-N-hydroxyacrylamide 17%
66. Cell Death 17%
67. Databases 17%
68. Glycosides 17%
69. Serum 16%
70. Reactive Oxygen Species 16%
71. Mass Spectrometry 16%
72. Hydrolyzable Tannins 16%
73. Histone Deacetylase 6 16%
74. Acetylation 16%
75. Solubility 16%
76. Antrodia 16%
77. benzenesulfonamide 16%
78. Hepatocellular Carcinoma 16%
79. Vorinostat 15%
80. Chinese Traditional Medicine 15%
81. hispidulin 15%
82. Wounds and Injuries 15%
83. Tablets 15%
84. Messenger RNA 15%
85. Structure-Activity Relationship 15%
86. Neoplasm Metastasis 14%
87. Prostatic Neoplasms 14%
88. Confidence Intervals 14%
89. Calcium 14%
90. RAW 264.7 Cells 14%
91. A549 Cells 14%
92. Liver 14%
93. Drug Liberation 14%
94. Western Blotting 14%
95. Cantharidin 14%
96. Molecular Dynamics Simulation 14%
97. shikonin 14%
98. Hydroxamic Acids 14%
99. Caspase 3 14%
100. Matrix Metalloproteinases 14%

Chemical Compounds

1. Protein 59%
2. Drug 56%
3. Histone 53%
4. Antiproliferative 41%
5. Antiinflammatory 29%
6. Antioxidant Agent 29%
7. Antitumor 26%
8. Antineoplastic Agent 26%
9. Pharmacokinetics 25%
10. Plasma 24%
11. Nitric Oxide 24%
12. Metabolite 23%
13. Bioavailability 22%
14. Aristolochic Acid 20%
15. Apoptotic 19%
16. Percutaneous 19%
17. Dose 19%
18. High-Pressure Liquid Chromatography 18%
19. Acid 18%
20. Genetic Polymorphism 17%
21. Leaf Like Crystal 17%
22. Lipopolysaccharide 16%
23. Application 16%
24. Hydroxamic Acid 16%
25. Methylglyoxal 15%
26. Lignan 14%
27. Flavonoid 14%
28. 50 Percent Growth Inhibition 14%
29. Cell Death 14%
30. Cantharidin 14%
31. Glycoside 14%
32. Nanoparticle 14%
33. Micelle 13%
34. Reactive Oxygen Metabolite 13%
35. Marker 13%
36. Bioactivity 13%
37. Amount 13%
38. Hydrolysable Tannin 12%
39. Quercetin 12%
40. Colchicine 12%
41. Modification 12%
42. Column Like Crystal 12%
43. Free Radical 12%
44. Resveratrol 12%
45. Ethanol 12%
46. Polymerization Reaction 12%
47. Collagen 12%
48. Structure-Activity Relationship 12%
49. Resistance 12%
50. Shikonin 12%
51. Composite Material 11%
52. Protective 11%
53. Solubility 11%
54. Disorder 11%
55. Oxidative Stress 11%
56. Dissolution 11%
57. 3-Hydroxybutyrate 10%
58. Metabolic 10%
59. Tannin 10%
60. Alkannin 10%
61. Lipid 10%
62. Chitosan 10%
63. Glucose 10%
64. Microcrystallinity 10%
65. Prostaglandin E2 10%
66. Granulation 9%
67. Enantiomer 9%
68. Osthole 9%
69. Superoxide 9%
70. Vascular Targeting Agent 9%
71. Western Blotting 9%
72. Hydrogel 9%
73. Cell Viability 9%
74. Calcium(0) 9%
75. Time 9%
76. Succinate 9%
77. Retinal 9%
78. Sildenafil 9%
79. Prostaglandin E1 9%
80. Simulation 9%
81. Nifedipine 9%
82. Wogonin 8%
83. Weight 8%
84. Liquid Film 8%
85. Poly(ethylene Glycol) 8%
86. Acetylation 8%
87. Pharmacological Metabolism 8%
88. Liquid 8%
89. Liquid Chromatography 8%
90. Indoline 8%
91. Biological Marker 8%
92. Gel 8%
93. Hispidulin 8%
94. Antiapoptotic 8%
95. Fragmentation 8%
96. Diclofenac Sodium 8%
97. Flow 8%
98. Excipient 8%